GL1X · GenesisL1 explorer

Research workbench

E.COLI glpg Y205F mutant complexed with aldehyde inhibitor in DMPC/CHAPSO bicelle

Analyse E.COLI glpg Y205F mutant complexed with aldehyde inhibitor in DMPC/CHAPSO… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5F5J
Type
protein
Length
185 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Rhomboid protease glpg; Peptidic derivative of gurken: ACE-val-arg-met-ala- aldehyde
EC
3.4.21.105
UniProt
A0A0J2E248
Ligands
ACE
Pockets
2 · best druggability 0.45

Structure

x-ray diffraction · 2 distinct chains · 76% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARhomboid protease glpg (EC 3.4.21.105)protein18178% helix, 2% strandA0A0J2E248
BPeptidic derivative of gurken: ACE-val-arg-met-ala- aldehydeprotein40% helix, 50% strand—

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1820.450.8016empty
2610.320.7516empty

Interfaces

1 interface between chains.

  • A–B · 474 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent, 1 modified (covalent ligand, nonstandard).

Compared structures

  • 5F5J · E.coli GlpG Y205F mutant complexed with aldehyde inhibitor in DMPC/CHAPSO bicelle · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.